Nasdaq · CIK 0001689375
TRDA Entrada Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 33 d ago. Close $5.67 on Oct 9, 2026, +5% from the 52-week low and -65% from the high.
Last 90 days
Net insider value
-$5.0M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
4
$5.0M by 2 insiders
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
TRDAOct 9, 2026 · close 5.67
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Entrada Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | MPM BioVentures 2014, L.P. owner sell | $1.9M 259,837 shares | -6% | - | |
| 45Moderate | Mpm Bioventures 2018, L.p. owner sell | $1.9M 259,837 shares | -6% | - | |
| 40Moderate | MPM BioVentures 2014, L.P. owner sell | $617k 86,482 shares | -2% | - | |
| 40Moderate | Mpm Bioventures 2018, L.p. owner sell | $617k 86,482 shares | -2% | - | |
| 36Weak | Baker Bros. Advisors LP owner buy | $262k 28,867 shares | +8% | +83% from low-58% from high | |
| 37Weak | 5AM Ventures V, L.P. owner sell | $1.8M 200,000 shares | -6% | +74% from low-59% from high | |
| 46Moderate | Baker Bros. Advisors LP owner buy | $1.4M 178,044 shares | +49% | +45% from low-66% from high | |
| 32Weak | 5AM Ventures V, L.P. owner sell | $203k 27,000 shares | -1% | +13% from low-65% from high | |
| 35Weak | Kush Parmar director, owner sell | $203k 27,000 shares | -1% | +13% from low-65% from high | |
| 43Moderate | 5AM Ventures V, L.P. owner sell | $867k 125,000 shares | -4% | 0% from low-68% from high | |
| 46Moderate | Kush Parmar director, owner sell | $867k 125,000 shares | -4% | 0% from low-68% from high | |
| 46Moderate | Peter S Kim director buy | $732k 50,000 shares | +74% | - | |
| 2Weak | Kory James Wentworth Chief Financial Officer sell | $19k 1,784 shares | -2% | - | |
| 51Moderate | MPM BioVentures 2014, L.P. owner sell | $917k 44,722 shares | -1% | - | |
| 51Moderate | Mpm Bioventures 2018, L.p. owner sell | $917k 44,722 shares | -1% | - | |
| 29Weak | Natarajan Sethuraman President, Research & Develop. sell | $321k 15,891 shares | -10% | - | |
| 12Weak | Kory James Wentworth Chief Financial Officer sell | $120k 6,000 shares | -8% | - | |
| 11Weak | Kory James Wentworth Chief Financial Officer sell | $173k 8,637 shares | -10% | - | |
| 17Weak | Natarajan Sethuraman President, Research & Develop. sell | $82k 4,109 shares | -2% | - | |
| 23Weak | Natarajan Sethuraman President, Research & Develop. sell | $339k 18,219 shares | -10% | - | |
| 0Weak | Natarajan Sethuraman President, Research & Develop. sell | $11k 600 shares | -0% | - |
Transactions
The last 99 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -38,500 | $7.11 | $274k | 4,106,452 | 33 d ago |
| Sep 4, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -38,500 | $7.11 | $274k | 4,106,452 | 33 d ago |
| Sep 8, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -192,500 | $7.41 | $1.4M | 3,913,952 | 33 d ago |
| Sep 8, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -192,500 | $7.41 | $1.4M | 3,913,952 | 33 d ago |
| Sep 9, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -28,837 | $7.13 | $206k | 3,885,115 | 33 d ago |
| Sep 9, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -28,837 | $7.13 | $206k | 3,885,115 | 33 d ago |
| Sep 2, 2026 | Dipal Doshi CEO | FTax withholding Common Stock | -8,724 | $7.14 | $62k | 517,290 | 39 d ago |
| Sep 2, 2026 | Nathan J Dowden President & COO | FTax withholding Common Stock | -2,528 | $7.14 | $18k | 196,060 | 39 d ago |
| Sep 2, 2026 | Kory James Wentworth Chief Financial Officer | FTax withholding Common Stock | -1,733 | $7.14 | $12k | 117,277 | 39 d ago |
| Sep 2, 2026 | Natarajan Sethuraman President, Research & Develop. | FTax withholding Common Stock | -2,079 | $7.14 | $15k | 214,238 | 39 d ago |
| Sep 1, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -29,088 | $7.06 | $205k | 4,202,346 | 39 d ago |
| Sep 1, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -29,088 | $7.06 | $205k | 4,202,346 | 39 d ago |
| Sep 2, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -25,131 | $7.19 | $181k | 4,177,215 | 39 d ago |
| Sep 2, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -25,131 | $7.19 | $181k | 4,177,215 | 39 d ago |
| Sep 3, 2026 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -32,263 | $7.17 | $231k | 4,144,952 | 39 d ago |
| Sep 3, 2026 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -32,263 | $7.17 | $231k | 4,144,952 | 39 d ago |
| Nov 20, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +1,213 | $9.07 | $11k | 380,152 | Nov 24, 2025 |
| Nov 20, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +13,386 | $9.07 | $121k | 4,678,310 | Nov 24, 2025 |
| Nov 20, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +1,186 | $9.07 | $11k | 381,338 | Nov 24, 2025 |
| Nov 20, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +13,082 | $9.07 | $119k | 4,691,392 | Nov 24, 2025 |
| Nov 14, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stock | -200,000 | $8.80 | $1.8M | 2,963,066 | Nov 18, 2025 |
| Nov 10, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +2,296 | $7.21 | $17k | 366,457 | Nov 12, 2025 |
| Nov 10, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +25,364 | $7.21 | $183k | 4,527,022 | Nov 12, 2025 |
| Nov 10, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +267 | $7.22 | $1,929 | 366,724 | Nov 12, 2025 |
| Nov 10, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +2,947 | $7.22 | $21k | 4,529,969 | Nov 12, 2025 |
| Nov 11, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +1,059 | $7.39 | $7,827 | 367,783 | Nov 12, 2025 |
| Nov 11, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +11,701 | $7.39 | $86k | 4,541,670 | Nov 12, 2025 |
| Nov 11, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +2,795 | $7.54 | $21k | 370,578 | Nov 12, 2025 |
| Nov 11, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +30,879 | $7.54 | $233k | 4,572,549 | Nov 12, 2025 |
| Nov 12, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +7,321 | $7.73 | $57k | 377,899 | Nov 12, 2025 |
| Nov 12, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +80,881 | $7.73 | $625k | 4,653,430 | Nov 12, 2025 |
| Nov 12, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +1,040 | $7.95 | $8,273 | 378,939 | Nov 12, 2025 |
| Nov 12, 2025 | Baker Bros. Advisors LP owner | POpen-market purchase Common Stockindirect: See Footnotes | +11,494 | $7.95 | $91k | 4,664,924 | Nov 12, 2025 |
| Sep 2, 2025 | Dipal Doshi CEO | FTax withholding Common Stock | -8,723 | $5.43 | $47k | 415,664 | Sep 4, 2025 |
| Sep 2, 2025 | Nathan J Dowden President & COO | FTax withholding Common Stock | -1,746 | $5.43 | $9,481 | 179,059 | Sep 4, 2025 |
| Sep 2, 2025 | Kory James Wentworth Chief Financial Officer | FTax withholding Common Stock | -1,734 | $5.43 | $9,416 | 118,936 | Sep 4, 2025 |
| Sep 2, 2025 | Natarajan Sethuraman President, Research & Develop. | FTax withholding Common Stock | -1,760 | $5.43 | $9,557 | 197,899 | Sep 4, 2025 |
| Jul 9, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stock | -20,065 | $7.50 | $151k | 3,163,066 | Jul 11, 2025 |
| Jul 9, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Ventures V, L.P. | -20,065 | $7.50 | $151k | 3,163,066 | Jul 11, 2025 |
| Jul 9, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,935 | $7.50 | $52k | 1,093,313 | Jul 11, 2025 |
| Jul 9, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,935 | $7.50 | $52k | 1,093,313 | Jul 11, 2025 |
| Jun 27, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Ventures V, L.P. | -55,735 | $6.91 | $385k | 3,220,287 | Jul 1, 2025 |
| Jun 27, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stock | -55,735 | $6.91 | $385k | 3,220,287 | Jul 1, 2025 |
| Jun 27, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -19,265 | $6.91 | $133k | 1,113,092 | Jul 1, 2025 |
| Jun 27, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -19,265 | $6.91 | $133k | 1,113,092 | Jul 1, 2025 |
| Jun 30, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stock | -18,578 | $6.81 | $127k | 3,201,709 | Jul 1, 2025 |
| Jun 30, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Ventures V, L.P. | -18,578 | $6.81 | $127k | 3,201,709 | Jul 1, 2025 |
| Jun 30, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,422 | $6.81 | $44k | 1,106,670 | Jul 1, 2025 |
| Jun 30, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,422 | $6.81 | $44k | 1,106,670 | Jul 1, 2025 |
| Jul 1, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stock | -18,578 | $7.12 | $132k | 3,183,131 | Jul 1, 2025 |
| Jul 1, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Ventures V, L.P. | -18,578 | $7.12 | $132k | 3,183,131 | Jul 1, 2025 |
| Jul 1, 2025 | Kush Parmar director, owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,422 | $7.12 | $46k | 1,100,248 | Jul 1, 2025 |
| Jul 1, 2025 | 5AM Ventures V, L.P. owner | SOpen-market sale Common Stockindirect: By 5AM Opportunities I, L.P. | -6,422 | $7.12 | $46k | 1,100,248 | Jul 1, 2025 |
| May 13, 2024 | Peter S Kim director | POpen-market purchase Common Stock | +25,000 | $14.68 | $367k | 92,412 | Jun 18, 2025 |
| May 14, 2024 | Peter S Kim director | POpen-market purchase Common Stock | +25,000 | $14.59 | $365k | 117,412 | Jun 18, 2025 |
| Jun 11, 2025 | Mary Thistle director | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 11, 2025 | Gina Chapman director | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 11, 2025 | Kush Parmar director, owner | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 11, 2025 | Bernhardt G Zeiher director | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 11, 2025 | Peter S Kim director | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 1, 2025 | Maha Radhakrishnan director | AGrant or award Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 3, 2025 |
| Apr 3, 2025 | Kory James Wentworth Chief Financial Officer | MOption exercise Common Stock | +11,134 | $2.10 | $23k | 120,670 | Apr 4, 2025 |
| Apr 3, 2025 | Kory James Wentworth Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative | -11,134 | $0.00 | $0 | 20,023 | Apr 4, 2025 |
| Mar 17, 2025 | Kory James Wentworth Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -1,784 | $10.67 | $19k | 109,536 | Mar 19, 2025 |
| Mar 1, 2025 | Kory James Wentworth Chief Financial Officer | AGrant or award Common Stock | +42,400 | $0.00 | $0 | 116,249 | Mar 4, 2025 |
| Mar 1, 2025 | Dipal Doshi CEO | AGrant or award Common Stock | +116,200 | $0.00 | $0 | 441,953 | Mar 4, 2025 |
| Mar 1, 2025 | Natarajan Sethuraman President, Research & Develop. | AGrant or award Common Stock | +60,800 | $0.00 | $0 | 205,797 | Mar 4, 2025 |
| Mar 1, 2025 | Nathan J Dowden President & COO | AGrant or award Common Stock | +60,800 | $0.00 | $0 | 185,949 | Mar 4, 2025 |
| Mar 3, 2025 | Dipal Doshi CEO | FTax withholding Common Stock | -17,566 | $11.68 | $205k | 424,387 | Mar 4, 2025 |
| Mar 3, 2025 | Nathan J Dowden President & COO | FTax withholding Common Stock | -5,144 | $11.68 | $60k | 180,805 | Mar 4, 2025 |
| Mar 3, 2025 | Natarajan Sethuraman President, Research & Develop. | FTax withholding Common Stock | -6,138 | $11.68 | $72k | 199,659 | Mar 4, 2025 |
| Mar 3, 2025 | Kory James Wentworth Chief Financial Officer | FTax withholding Common Stock | -4,929 | $11.68 | $58k | 111,320 | Mar 4, 2025 |
| Mar 1, 2025 | Dipal Doshi CEO | AGrant or award Stock Option (Right to Buy)derivative | +173,400 | $0.00 | $0 | 173,400 | Mar 4, 2025 |
| Mar 1, 2025 | Kory James Wentworth Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +63,300 | $0.00 | $0 | 63,300 | Mar 4, 2025 |
| Mar 1, 2025 | Nathan J Dowden President & COO | AGrant or award Stock Option (Right to Buy)derivative | +90,800 | $0.00 | $0 | 90,800 | Mar 4, 2025 |
| Mar 1, 2025 | Natarajan Sethuraman President, Research & Develop. | AGrant or award Stock Option (Right to Buy)derivative | +90,800 | $0.00 | $0 | 90,800 | Mar 4, 2025 |
| Dec 10, 2024 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -22,935 | $20.77 | $476k | 4,402,849 | Dec 12, 2024 |
| Dec 10, 2024 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -22,935 | $20.77 | $476k | 4,402,849 | Dec 12, 2024 |
| Dec 11, 2024 | MPM BioVentures 2014, L.P. owner | SOpen-market sale Common Stockindirect: See Footnote | -21,787 | $20.23 | $441k | 4,381,062 | Dec 12, 2024 |
| Dec 11, 2024 | Mpm Bioventures 2018, L.p. owner | SOpen-market sale Common Stockindirect: See Footnote | -21,787 | $20.23 | $441k | 4,381,062 | Dec 12, 2024 |
| Nov 29, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -100 | $20.00 | $2,000 | 160,788 | Dec 3, 2024 |
| Nov 29, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Common Stock10b5-1 | +1,000 | $2.10 | $2,100 | 74,849 | Dec 3, 2024 |
| Dec 2, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -4,088 | $20.26 | $83k | 156,700 | Dec 3, 2024 |
| Nov 29, 2024 | Kory James Wentworth Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -1,000 | $19.97 | $20k | 73,849 | Dec 3, 2024 |
| Dec 2, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Common Stock10b5-1 | +5,000 | $2.10 | $11k | 78,849 | Dec 3, 2024 |
| Dec 3, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -11,703 | $20.15 | $236k | 144,997 | Dec 3, 2024 |
| Dec 2, 2024 | Kory James Wentworth Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -5,000 | $20.00 | $100k | 73,849 | Dec 3, 2024 |
| Nov 29, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 36,157 | Dec 3, 2024 |
| Dec 2, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 31,157 | Dec 3, 2024 |
| Nov 11, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Common Stock10b5-1 | +6,000 | $2.10 | $13k | 82,486 | Nov 13, 2024 |
| Nov 11, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -1,409 | $20.01 | $28k | 163,588 | Nov 13, 2024 |
| Nov 13, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -2,700 | $20.04 | $54k | 160,888 | Nov 13, 2024 |
| Nov 11, 2024 | Kory James Wentworth Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -8,637 | $19.98 | $173k | 73,849 | Nov 13, 2024 |
| Nov 11, 2024 | Kory James Wentworth Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 37,157 | Nov 13, 2024 |
| Nov 4, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -749 | $18.02 | $13k | 182,467 | Nov 6, 2024 |
| Nov 5, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -5,171 | $18.18 | $94k | 177,296 | Nov 6, 2024 |
| Nov 6, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -9,554 | $18.71 | $179k | 167,742 | Nov 6, 2024 |
| Nov 6, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -2,745 | $19.32 | $53k | 164,997 | Nov 6, 2024 |
| Oct 16, 2024 | Natarajan Sethuraman President, Research & Develop. | SOpen-market sale Common Stock10b5-1 | -600 | $18.00 | $11k | 183,216 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- 5AM Ventures V, L.P.owner
- Baker Bros. Advisors LPdirector, owner, other
- Gina Chapmanceo, president, officer, director
- Dipal DoshiCEO
- Nathan J DowdenPresident & COO
- Peter S Kimdirector
- Mpm Bioventures 2018, L.p.owner, other
- MPM BioVentures 2014, L.P.owner, other
- Kush Parmarowner, director
- Maha Radhakrishnandirector
- Natarajan SethuramanPresident, Research & Develop.
- Mary Thistledirector
- Kory James WentworthChief Financial Officer
- Bernhardt G Zeiherdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.